Introduction. Spinal Cord Injury (SCI) Is it necessary to perform surveillance investigations for long term follow up of spinal cord injury patients?

Similar documents
Summary. Neuro-urodynamics. The bladder cycle. and voiding. 14/12/2015. Neural control of the LUT Initial assessment Urodynamics

Guidelines on Neurogenic Lower Urinary Tract Dysfunction

Spinal Cord Injury. R Hamid Consultant Neuro-Urologist London Spinal Injuries Unit, Stanmore & National Hospital for Neurology & Neurosurgery, UCLH

GUIDELINES ON NEUROGENIC LOWER URINARY TRACT DYSFUNCTION

Recommandations de prise en charge des vessies neurogènes EAU 2006

Neuropathic Bladder. Magda Kujawa Consultant Urologist Stockport NHS Foundation Trust 12/03/2014

THE ACONTRACTILE BLADDER - FACT OR FICTION?

NEUROGENIC BLADDER. Dr Harriet Grubb Dr Alison Seymour Dr Alexander Joseph

GUIDELINES ON NEURO-UROLOGY

Neurogenic bladder. Neurogenic bladder is a type of dysfunction of the bladder due to neurological disorder.

Pelvic Floor Therapy for the Neurologic Client Carina Siracusa, PT, DPT, WCS

GUIDELINES ON NEURO-UROLOGY

Diagnostic approach to LUTS in men. Prof Dato Dr. Zulkifli Md Zainuddin Consultant Urologist / Head Of Urology Unit UKM Medical Center

Tools for Evaluation. Urodynamics Case Studies. Case 1. Evaluation. Case 1. Bladder Diary SUI 19/01/2018

Urinary Incontinence. Vibhash Mishra Consultant Urological Surgeon Royal Free Hospital

Lower Urinary Tract Symptoms K Kuruvilla Zachariah Associate Specialist

Urinary Aspects of Multiple Sclerosis chronic condition with innovative treatment strategies. Dr. Boris Friedman May 2, 2012 OBJECTIVES

Rehabilitation and Metastatic Spinal Cord Compression

Lower Urinary Tract Symptoms (LUTS) and Nurse-Led Clinics. Sean Diver Urology Advanced Nurse Practitioner candidate Letterkenny University Hospital

Incontinence in neurological disease

Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline.

EAU GUIDELINES ON NEURO-UROLOGY

GUIDELINES ON URINARY INCONTINENCE

Urodynamics in Neurological Lower Urinary Tract Dysfunction. Mr Chris Harding Consultant Urologist Freeman Hospital Newcastle-upon-Tyne

Neurogenic Bladder. Spina Bifida Education Day Conference SBA of Northeastern New York Albany, New York April 14, Eric Levey, M.D.

Clinical guideline Published: 8 August 2012 nice.org.uk/guidance/cg148

Clinical Study Predictors of Response to Intradetrusor Botulinum Toxin-A Injections in Patients with Idiopathic Overactive Bladder

Multiple Sclerosis. Véronique Phé, MD, PhD Pitié-Salpêtrière Academic Hospital Department of Urology Paris 6 University Paris, FRANCE

Male Lower Urinary Tract Symptoms: Management in primary care and beyond. Daniel Cohen PhD FRCS(Urol) Consultant Urological Surgeon

Center for Reconstructive Urethral Surgery Guido Barbagli Center for Reconstructive Urethral Surgery Arezzo - Italy

The Enlarged Prostate Symptoms, Diagnosis and Treatment

Management of Female Stress Incontinence

A joint venture between the Department of Uro-Neurology, Queen Square, University College London and the Neuro-Urology Promotion Committee of the ICS

Post operative voiding dysfunction and the Value of Urodynamics. Dr Salwan Al-Salihi Urogynaecologist Obstetrician and Gynaecologist

EAU GUIDELINES ON NEURO-UROLOGY

Scottish Health Technologies Group

Physicians are required to be scrupulously honest in their dealings with the College.

D-MANNOSE, CRANBERRY AND VITAMIN C (CYSTOMAN 100MG) ARE EFFECTIVE IN PREVENTING URINARY TRACT INFECTIONS IN MULTIPLE SCLEROSIS SUBJECTS.

Urogynecology in EDS. Joan L. Blomquist, MD Greater Baltimore Medical Center August 2018

Overactive bladder can result from one or more of the following causes:

Selected Bibliography

The Neurogenic Bladder and Telemedicine: urologic history and physical exam development with a. Objectives

GUIDELINES ON URINARY INCONTINENCE

Managing urinary retention for a young man

How to manage a patient with bladder dysfunction

Bladder Management. A guide for patients. Key points

The Neurogenic Bladder

CASES FOR TRAINING OF THE INTERNATIONAL SPINAL CORD INJURY LOWER URINARY TRACT FUNCTION BASIC DATA SET CASE 1

A Novel New Approach to Treatment of Catastrophic Urinary Dysfunction

Hong Kong College of Surgical Nursing

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

THE RISK OF URINARY RETENTION AFTER NERVE-SPARING SURGERY FOR DEEP INFILTRATING ENDOMETRIOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

Diagnosis and Mangement of Nocturia in Adults

Portable Bladder Ultrasound. OHTAC Recommendation. Portable Bladder Ultrasound

An Anteriorly Positioned Midline Prostatic Cyst Resulting in Lower Urinary Tract Symptoms

Outcomes Primary Outcomes Secondary Outcomes Tertiary Outcomes

An Effective Day Case Treatment Combination for Refractory Neuropathic Mixed Incontinence

Stimulation of the Sacral Anterior Root Combined with Posterior Sacral Rhizotomy in Patients with Spinal Cord Injury. Original Policy Date

MANAGING BENIGN PROSTATIC HYPERTROPHY IN PRIMARY CARE DR GEORGE G MATHEW CONSULTANT FAMILY PHYSICIAN FELLOW IN SEXUAL & REPRODUCTIVE HEALTH

Asyntomatic bacteriuria, Urinary Tract Infection

CONTINENCE MODULE 1 MIMIMUM STANDARDS FOR THE SPECIALIST ASSESSMENT & CONSERVATIVE MANAGEMENT OF FEMALE LOWER URINARY TRACT SYMPTOMS

Update on Haematuria and Bladder Cancer

NON-Neurogenic Chronic Urinary Retention AUA White Paper

University of Bristol - Explore Bristol Research

Original Article. Annals of Rehabilitation Medicine INTRODUCTION

Incontinence; Lets talk about it. Karanvir Virk M.D. Minimally Invasive and Pelvic Reconstructive Surgery

Overactive Bladder Syndrome

INCONTINENCE AND OTHER UROLOGICAL DILEMMAS DR. ANNA LAWRENCE UROLOGIST AUCKLAND HOSPITAL 161 UROLOGY

OHTAC Recommendation

Urinary incontinence. Urology Department. Patient Information Leaflet

PRE-OPERATIVE URODYNAMIC

Managing urinary morbidity after brachytherapy. Kieran O Flynn Department of Urology, Salford Royal Foundation Trust, Manchester

Video-urodynamics. P J R Shah Institute of Urology and UCH

INJ. Incontinence Pad Usage in Medical Welfare Facilities in Korea. Original Article INTRODUCTION

Mr. GIT KAH ANN. Pakar Klinikal Urologi Hospital Kuala Lumpur.

Practical urodynamics What PA s need to know. Gary E. Lemack, MD Professor of Urology and Neurology

URODYNAMICS IN MALE LUTS: NECESSARY OR WASTE OF TIME?

The inflow. Active Urologic Practice. Clinical Background and Urology Practice Overview

Onabotulinumtoxin - A Injections for the Treatment of Neurogenic Detrusor Overactivity

Robotic Appendicovesicostomy

2/9/2008. Men Women. Prevalence of OAB. Men: 16.0% Women: 16.9% Prevalence (%) < Age (years)

Neural control of the lower urinary tract

INTERNATIONAL SPINAL CORD INJURY DATA SETS URINARY TRACT IMAGING BASIC DATA SET - COMMENTS

Functional outcome of patients with spinal cord injury: rehabilitation outcome study

NEUROMODULATION FOR UROGYNAECOLOGISTS

Complications Audit of Urological Issues in Spinal Cord Injury Evaluation Study (CAUSES)

TREATMENT METHODS FOR DISORDERS OF SMALL ANIMAL BLADDER FUNCTION

UNIVERSA MEDICINA. Effect of clean intermittent self-catheterization on urinary tract infection in subject with spinal cord injury

Objectives. Prevalence of Urinary Incontinence URINARY INCONTINENCE: EVALUATION AND CURRENT TREATMENT OPTIONS

UK Consensus on Bladder Management in MS

What should we consider before surgery? BPH with bladder dysfunction. Inje University Sanggye Paik Hospital Sung Luck Hee

Management of OAB. Lynsey McHugh. Consultant Urological Surgeon. Lancashire Teaching Hospitals

Continence Care Case Reports

Managing Patients with Neurogenic Detrusor Overactivity A Global Approach

A Prospective Study of Urinary Retention and Risk of Death after Proximal Femoral Fracture

University of Groningen. Functional outcome after spinal cord injury Schonherr, Marleen C.

Case Based Urology Learning Program

Clinical and Laboratory Evidence

Slide 1. Slide 2. Slide 3. Bladder Management and Preventing CAUTI. Bladder management CAUTI prevention standards

Transcription:

Is it necessary to perform surveillance investigations for long term follow up of spinal cord injury patients? Rizwan Hamid MBBS, FRCSEd, FRCS(Urol), MD(Res) Honorary Senior Lecturer & Consultant Urologist London Spinal Injuries Centre & University College London Hospitals 1 Introduction Bladder dysfunction in SCI patients Aims of treatment / follow-up in SCI population The investigations for urinary tract monitoring Current surveillance study Similar studies for long term follow-up International Guidelines Summary Future Conclusions Prevalence Europe: 252 per million 1 SCI with Bladder Dysfunction: Vast majority with SCI have voiding dysfunction 2 Total with UI Europe: ~19% 3 Type of Disease: Majority are a result of trauma 2 Age of Onset: Majority 30 40 years old and male 4 Life Expectancy: Spinal Cord Injury (SCI) Spinal cord lesions can be traumatic, vascular, medical or congenital 5 Related to severity of injury 4 1. Wyndaele M et al. Spinal Cord. 2006;44:523-529. 2. Bladder Management for Adults with Spinal Cord Injury. Consortium for Spinal Cord Medicine. August 2006. 3. Guly HR. Resuscitation. 2008;76(1):57-62. 4. Foundation for SCI Prevention, Care & Cure. Spinal Cord Injury Facts. Available at: www.fscip.org/facts.htm. Accessed April 2013. 5. Pannek J. European Association of Urology. Guidelines on neurogenic lower urinary tract dysfunction. 2011. http://www.uroweb.org/gls/pdf/17_neurogenic%20luts.pdf. Accessed April 2013. 4 1

Bladder symptoms in neurogenic diseases Frequency, urgency & incontinence are commonly reported in NDO population 10% of patients with stroke develop NBD 1 in 10 patients present with bladder symptoms at time of MS diagnosis 2 Up to 75% of MS patients report some form of UI 3 Vast majority of SCI patients have NBD 4 Aims of treatment of NBD Protection of the upper urinary tract Achieving urinary continence Improvement in QoL Restoration of LUT function Avoiding complications Cost effectiveness of treatment 1. Patel et al Stroke 2001; 32: 122-127; 2. McCombe PA et al. Expert Rev Neurotherap. 2009;9:331-340 5; 3. Mahajan ST et al. J Urol. 2010;183:1432-1437 4. Bladder Management for Adults with Spinal Cord Injury. Consortium for Spinal Cord Medicine. August 2006 1. Stohrer M. Eur Urol 2009;56:81 8. 2. Pannek J. European Association of Urology. Guidelines on neurogenic lower urinary tract dysfunction. 2011. Available from http://www.uroweb.org/gls/pdf/17_neurogenic% 20LUTS.pdf. Spinal Cord Injury: survival The consequence of effective therapy Long Term Survival 20 year survival First world war (1914-1918) <5% Second World war (1939-1945) 29% Korean war (1950-1953) 64% Present day 85% Improved life expectancy Compared to general population Cervical lesions 79% Thoracic/lumbar lesions 86% Complete lesion: mean life expectancy 70% for tetraplegics 84% for paraplegics Incomplete lesions: mean life expectancy More than 90% for both tetra & paraplegics JD Yeo et al, spinal cord. 1998 May; 36(5) 2

Post SCI causes of death Main causes of death post SCI are: -Septicaemia -Pneumonia -Urinary tract disease -Suicide However, the Major cause of death in 1 st two years post SCI is urinary tract disease Surveillance investigations of SCIP Video urodynamics studies Renal ultrasound scans Screening cystoscopy for Ca bladder to detect any significant urinary tract abnormalities The protocol for undertaking these studies is not standardised but it is generally agreed that SCI patients do need a life long follow-up Soden RJ, Walsh J. Causes of death after spinal cord injury: Spinal Cord:2000 Oct;38(10):604-10. 10 Current Study The aim of this study was to assess if there is a need for regular imaging studies in follow up of SCI patients Methods We evaluated the role of VCMG or USS in influencing the management decisions of SCI patients with a minimum of 5 years follow up All patient admitted to our SCI centre in a single year (2005) were included in the study All VCMG or USS undertaken as part of patient s bladder rehabilitation programme were evaluated All follow up changes were recorded during the 5 year period to 2010 11 12 3

Results A total of 23 patients were identified There were 15 male and 8 females All had a traumatic SCI 18 were upper motor neuron lesion 5 had a lower motor neuron lesion The patients had an average of 2.5 USS Results All but three patients underwent VCMG The remaining 3 patients did not complain of any urinary symptoms and had a normal flow rate with no significant residual urine Patients had an average of 2.1 (0-4) VCMG 13 14 Results Seventeen (74%) otherwise asymptomatic patients had a change in their management instituted as a result of these investigations Results Pts required surgical change Pts required medical change Pts required no changes VCMG USS VCMG USS 9 of them underwent a surgical intervention Botox injection to bladder STING procedure Anti-incontinence operations UMNL LMNL 7/18 (33.3) 1/5 (20) 1/18 (5.5) 0/5 7/18 (38) 1/5 (20) 0/18 0/5 3/18 (16.6) 3/5 (60) 15 16 4

Summary of study Bladder dysfunction after SCI is a dynamic process Most of these changes occur in patients with UMNL The changes in lower & upper tract can be insidious and a high index of suspicion is required We feel a proactive approach with regular VCMG and USS in asymptomatic patients is necessary to keep the urinary tract safe in this patient group 17 Lisenmeyer TA, J Spinal Cord Med:2013:36:420-26 Urodynamic changes were compared with their previous annual urodynamic evaluation The main outcome measure was whether or not there was a need for an intervention based on the urodynamics Impact of type of bladder management & level of injury was evaluated Ninety-six consecutive individuals with SCI undergoing annual urodynamic evaluations were enrolled over a 5-month period 47.9% of individuals required at least one type of intervention based on urodynamic studies 82.6% were urological interventions The need for interventions did not appear to be influenced by the type of bladder management or level of injury Annual urodynamic evaluation plays an important role in guiding bladder management following SCI Patki P, Hamid R. et al:j Urol:2006:175:1784-87 Patients attending with isci during a 2-year period were identified At the time of discharge 40/64 patients (62.5%) could void spontaneously 19/40 patients (47.5%) who had been initially assessed as having a bladder that was safe to void spontaneously required SIC Conversely 5/20 patients (25%) who initially required CSIC improved At last follow-up 68.7% of the patients had abnormal urodynamics 24/64 (37.5%) required a change in urological management despite no appreciably detectable neurological change Despite relatively near total neurological recovery patients with incomplete SCI have neuropathic bladder unless proved otherwise Salient deterioration in bladder dysfunction is not uncommon Regular urological monitoring and appropriate treatment changes are required in the long term 5

Longitudinal cohort study spanning 6 years, studying patients with SCI for at least 20 years Structural/ functional renal deficits accumulate over time for all management methods High proportion of patients change bladder management method over time Indwelling catheters are the method of last resort Spinal Cord:2010:48:257-61 SCI is known risk factor for Ca bladder (16-28) All CaB in SCI patients over 14 years 32 identified 46.9% SCC Primary bladder management was urethral in 44% Mean duration was 33.3 years 42% detected on screening cystoscopy 36 SCI patients with long tern SPC Mean duration 12.1 years Yearly screening bladder biopsies No tumors identified SCI is a risk factor and long term screening is required for all 6

Guidelines for follow up of patients with Neurogenic bladder Summary Bladder management in SCI patients is a dynamic process Lifelong follow up is essential It appears that surveillance investigations should be undertaken regularly to optimise the function of LUT EAU Guidelines 2012 edition Future High quality trials are required & possible Multicentre studies to be undertaken MS/ SCI predominance; what about other conditions - stroke, dementia, Parkinson s? Problems caused by the heterogeneous population Neurological variability Confounded by non-neurological processes; aging, childbirth Achieving equipoise; e.g. urodynamics in MS Methodological flaws e.g. cross-sectional cohorts Conclusions Bladder dysfunction after SCI is a dynamic process Most of these changes can occur in patients with UMNL The changes in lower & upper tract can be insidious and a high index of suspicion is required A proactive approach with regular VCMG and USS in asymptomatic patients is necessary to keep the urinary tract safe in this patient group Life long follow-up of SCI patients is recommended 27 28 7

Thank you 29 8